Null and Noteworthy: Arbaclofen results; another oxytocin edition

New data from clinical trials of arbaclofen and oxytocin underscore the murkiness of null results. Plus, researchers seek clarity on the neurodevelopmental effects of oxytocin during childbirth.

Episode metadata supplied by the publisher feed · Published May 31, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Null and Noteworthy: Arbaclofen results; another oxytocin edition

0:00 4:26

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Audio research news?

This episode is 4 minutes long.

When was this Audio research news episode published?

This episode was published on May 31, 2023.

Can I download this Audio research news episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!